Abiopharma

Modivcare Inc. - Modivcare Receives Nasdaq Delisting Notice Following Chapter 11 Filing

Modivcare Receives Nasdaq Delisting Notice Following Chapter 11 Filing

Aptose Biosciences Announces Results of Reconvened Annual and Special Shareholders Meeting and Appointment of Ernst & Young LLP as New Auditor

New Form S-3 - INTELLIGENT BIO SOLUTIONS INC. Filed: 2025-08-22 AccNo: 0001493152-25-012272 Size: 494 KB

New Form 8-K - CareCloud, Inc. Filed: 2025-08-22 AccNo: 0001493152-25-012273 Size: 249 KB Item 1.02: Termination of a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

Aptose Biosciences Announces Results of Reconvened Annual and Special Shareholders Meeting and Appointment of Ernst & Young LLP as New Auditor

Triller Group Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)

Bath & Body Works to Present at the Goldman Sachs 32nd Annual Global Retailing Conference

High Tide Resources Announces Closing of Non-Brokered Private Placement

Beneficient Receives Additional Nasdaq Listing Determination

Trimarchi Thomas 🔴 sold 42.2K shares of BridgeBio Pharma, Inc. (BBIO) at $49.48 ($2.1M) Transaction Date: Aug 21, 2025 | Filing ID: 111011

Kalia Kumud 🔴 sold 2.0K shares of Guardant Health, Inc. (GH) at $61.76 Transaction Date: Aug 21, 2025 | Filing ID: 000264

New Form 144 - Phreesia, Inc. Filed: 2025-08-22 AccNo: 0001959173-25-005481 Size: 11 KB

New Form S-3ASR - ETHZilla Corp Filed: 2025-08-22 AccNo: 0001213900-25-079962 Size: 923 KB

New Form 144 - SUPERNUS PHARMACEUTICALS, INC. Filed: 2025-08-22 AccNo: 0001950047-25-006272 Size: 7 KB